Overview

Oslo Antioxidant Study

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to test whether increasing the total intake of antioxidants to middle-aged smoking men increases the antioxidant defence, reduces oxidative damage, and improves biomarkers for oxidative stress. The secondary objectives is to test whether this strategy improves other cardiovascular risk markers including platelet function, lipid levels, inflammation, and markers of endothelial damage.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Oslo
Collaborator:
Ullevaal University Hospital
Treatments:
Antioxidants